The American Joint Committee on Cancer (AJCC) TNM classification and the International Federation of Gynecology and Obstetrics (FIGO) staging system for cervical cancer are provided below.[1, 2, 3]
Table 1. TNM and FIGO Classifications for Cervical Cancer (Open Table in a new window)
Primary tumor (T) |
||
TNM |
FIGO |
Surgical-Pathologic Findings |
Categories |
Stages |
|
TX |
|
Primary tumor cannot be assessed |
T0 |
|
No evidence of primary tumor |
Tis |
|
Carcinoma in situ (preinvasive carcinoma) |
T1 |
I |
Cervical carcinoma confined to the cervix (disregard extension to the corpus) |
T1a |
IA |
Invasive carcinoma diagnosed only by microscopy; stromal invasion with a maximum depth of < 5.0 mm, measured from the base of the epithelium; vascular space involvement, venous or lymphatic, does not affect classification
|
T1a1 |
IA1 |
Measured stromal invasion < 3.0 mm in depth |
T1a2 |
IA2 |
Measured stromal invasion ≥ 3.0 mm and < 5.0 mm |
T1b |
IB |
Invasive carcinoma with measured deepest invasion ≥ 5 mm (greater than stage IA), lesion limited to the cervix |
T1b1 |
IB1 |
Invasive carcinoma with ≥ 5 mm depth of stromal invasion and < 2 cm in greatest dimension |
T1b2 |
IB2 |
Invasive carcinoma, 2 cm to < 4 cm in greatest dimension |
T1b3 |
IB3 |
Invasive carcinoma, ≥ 4 cm in greatest dimension |
T2 |
II |
Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina |
T2a |
IIA |
Involvement limited to the upper two-thirds of the vagina, without parametrial invasion |
T2a1 |
IIA1 |
Invasive carcinoma < 4 cm in greatest dimension |
T2a2 |
IIA2 |
Invasive carcinoma ≥ 4 cm in greatest dimension |
T2b |
IIB |
Tumor with parametrial invasion but not up to the pelvic wall |
T3 |
III |
Carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or para-aortic lymph nodes |
T3a |
IIIA |
Tumor involves lower third of vagina, with no extension to pelvic wall |
T3b |
IIIB |
Tumor extends to pelvic wall and/or causes hydronephrosis or nonfunctional kidney |
T3c |
IIIC |
Involvement of pelvic and/or para-aortic lymph nodes, irrespective of tumor size and extent (with r [imaging] and p [pathology] notations) |
T3c1 |
IIIC1 |
Pelvic lymph node metastasis only |
T3c2 |
IIIC2 |
Para-aortic lymph node metastasis |
T4 |
IV |
The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to stage IV.) |
|
IVA |
Spread to adjacent pelvic organs |
|
IVB |
Spread to distant organs |
Regional lymph nodes (N) |
||
NX |
Regional lymph nodes cannot be assessed |
|
N0 |
No regional lymph node metastasis |
|
N0 (i+) |
Isolated tumor cells in regional lymph node(s) ≤ 0.2 mm |
|
N1 |
Regional lymph node metastasis |
|
Distant metastasis (M) |
||
M0 |
No distant metastasis |
|
M1 |
Distant metastasis (including peritoneal spread; involvement of supraclavicular, mediastinal, or distant lymph nodes; and lung, liver, or bone) |
Table 2. AJCC Prognostic Groups (Open Table in a new window)
Stage |
Tumor |
Node |
Metastasis |
I |
T1 |
Any N |
M0 |
IAI |
T1a |
Any N |
M0 |
IA2 |
T1a1 |
Any N |
M0 |
IB |
T1b |
Any N |
M0 |
IB1 |
T1b1 |
Any N |
M0 |
IB2 |
T1b2 |
Any N |
M0 |
II |
T2 |
Any N |
M0 |
IIA |
T2a |
Any N |
M0 |
IIA1 |
T2a1 |
Any N |
M0 |
IIA2 |
T2a2 |
Any N |
M0 |
IIB |
T2b |
Any N |
M0 |
III |
T3 |
Any N |
M0 |
IIIA |
T3a |
Any N |
M0 |
IIIB |
T3b |
Any N |
M0 |
IVA |
T4 |
Any N |
M0 |
IVB |
Any T |
Any N |
M1 |